Jianming Cai Selected Research

Fibrosis (Cirrhosis)

11/2022	Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis.
1/2022	Severe Thrombocytopenia and Disseminated Intravascular Coagulation in a Cirrhosis Patient After Intravenous Injection of Gadoxetic Acid.
1/2021	Evaluating the clinical value of MRI multi-model diffusion-weighted imaging on liver fibrosis in chronic hepatitis B patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianming Cai Research Topics

Disease

28	Neoplasms (Cancer) 02/2024 - 02/2002
9	Hemorrhage 01/2022 - 03/2006
8	Pathologic Constriction (Stenosis) 10/2023 - 08/2002
8	Wounds and Injuries (Trauma) 10/2020 - 03/2002
6	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2019
6	Radiation Injuries (Radiation Sickness) 09/2023 - 03/2011
6	Lymphoma (Lymphomas) 01/2020 - 03/2011
6	Carotid Artery Diseases 09/2019 - 08/2002
5	Stroke (Strokes) 10/2023 - 01/2010
4	Body Weight (Weight, Body) 04/2024 - 01/2013
4	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2011
4	Lung Injury 01/2021 - 07/2014
4	Carcinogenesis 01/2020 - 04/2011
3	Thrombosis (Thrombus) 10/2023 - 03/2002
3	Fibrosis (Cirrhosis) 11/2022 - 01/2021
3	Carotid Stenosis (Carotid Artery Stenosis) 01/2010 - 03/2006
2	Hypoxia (Hypoxemia) 04/2024 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2021
2	Colitis 01/2023 - 01/2023
2	Rupture 01/2021 - 06/2011
2	Hepatocellular Carcinoma (Hepatoma) 06/2017 - 08/2002
2	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2015 - 03/2013
2	Hematologic Diseases (Blood Diseases) 03/2013 - 01/2013
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2013 - 06/2012
2	Reperfusion Injury 03/2010 - 01/2010
2	Necrosis 04/2004 - 02/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024
1	Moyamoya Disease (Moya-Moya Disease) 01/2024
1	Chronic Renal Insufficiency 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 09/2023
1	COVID-19 06/2023
1	Poisoning 11/2022
1	Portal Hypertension 11/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Disseminated Intravascular Coagulation 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Atherosclerosis 12/2019

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 01/2022 - 03/2006
8	HydrogenIBA 04/2014 - 01/2010
6	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 03/2013
5	Therapeutic UsesIBA 02/2024 - 10/2006
5	Phenobarbital (Luminal)FDA Link 10/2023 - 07/2007
5	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2011
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2006
3	roxadustatIBA 04/2024 - 01/2019
3	Long Noncoding RNAIBA 09/2023 - 01/2021
3	polydatinIBA 09/2023 - 12/2017
3	AntioxidantsIBA 01/2017 - 01/2010
3	Hydroxyl RadicalIBA 04/2011 - 01/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2024 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2019
2	CytokinesIBA 01/2021 - 03/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	Sirtuin 3IBA 01/2021 - 12/2017
2	CarbonIBA 10/2020 - 03/2018
2	Messenger RNA (mRNA)IBA 01/2020 - 06/2006
2	monophosphoryl lipid AIBA 01/2019 - 10/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2017 - 01/2017
2	OligodeoxyribonucleotidesIBA 01/2017 - 07/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2014 - 10/2007
2	CalciumIBA 08/2013 - 06/2010
2	SolutionsIBA 01/2013 - 04/2011
2	Peroxynitrous Acid (Peroxynitrite)IBA 03/2010 - 01/2010
2	Protons (Proton)IBA 01/2010 - 07/2006
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Hematoxylin (Haematoxylon)IBA 02/2024
1	Radioisotopes (Radionuclides)IBA 02/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024
1	Interleukin-17 (Interleukin 17)IBA 02/2024
1	scleroglucanIBA 02/2024
1	ZincIBA 01/2024
1	PlatinumIBA 07/2023
1	SaltsIBA 01/2023
1	Dextran SulfateIBA 01/2023
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2022
1	4-(3-chlorophenylsulfanyl)piperidineIBA 11/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 07/2021
1	Glucosamine (Dona)IBA 07/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Radiation-Protective Agents (Radiation Protectants)IBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2021
1	Grape Seed ProanthocyanidinsIBA 01/2021
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021
1	DNA-Activated Protein KinaseIBA 01/2021
1	Fumigant 93 (D-D)IBA 01/2021
1	SmokeIBA 01/2020
1	HomocysteineIBA 12/2019

Therapy/Procedure

21	Radiotherapy 02/2024 - 02/2002
10	Therapeutics 02/2024 - 10/2007
2	Drug Therapy (Chemotherapy) 07/2023 - 01/2023
2	Transplantation 01/2017 - 03/2015
2	Hematopoietic Stem Cell Transplantation 03/2015 - 03/2013
1	Chemoradiotherapy 09/2023
1	Neoadjuvant Therapy 09/2023
1	Aftercare (After-Treatment) 06/2023
1	Intravenous Injections 01/2022
1	Punctures 01/2021